Phospholipids (PL) are involved in a variety of cellular events. In platelets, they play important roles in signal transduction processes resulting from cell activation (1) (2) . The generation of diacylglycerols through the action of phospholipases C activates several metabolic cascades leading to various effects including protein phosphorylation, granule secretion and release of fatty acids by di-and monoacylglycerol lipases (3) (4) . In addition, platelet activation stimulates the activity of phospholipases A 2 (PLA 2 ) that cleave fatty acids from the sn 2 position of PL. In particular, the cytosolic PLA 2 reaction favors the liberation of arachidonic acid which is the precursor of prostaglandins and leukotrienes that are generated through the actions of cyclooxygenase and lipoxygenase, respectively (5) (6) . Thus, in activated platelets, membrane PL may be actively degraded, which necessitates their regeneration to maintain their cellular functions. Although PL may be resynthesized in platelets (7), a substantial part has been shown to be imported from extracellular sources (8) (9) (10) . In vivo, platelets are in contact with circulating lipoproteins that constitute a major source of PL. Previous in vitro works have shown that phosphatidylcholine (PC), phosphatidylethanolamine (PE) and sphingomyelin can be transfered from low (LDL)-and high density lipoproteins (HDL) to human platelets (8) . However the underlying mechanisms of these transfers appeared to be complex. Although platelets possess high affinity binding sites for LDL, PL transfers were independent of LDL binding or internalization (9) . In agreement with this finding, the scavenger receptor B1 which can mediate the specific import of PL into various cells was shown to be absent in platelets (10) . In addition, the uptake of PC and PE species by platelets appeared to be regulated by different mechanisms. The transfer of LDL or HDL -derived PE into platelets, but not that of PC or sphingomyelin, was stimulated by platelet activators including thrombin, collagen and 4 hepatic lipase, which ultimately results in the formation of LDL (12) (13) . During this process, the excess of VLDL surface components, including apolipoproteins, cholesterol and PL, is released from the particles. A large part of cholesterol and PL is transferred to HDL serving as substrates for the lecithin-cholesterol acyl transferase-mediated generation of cholesteryl esters (14) (15) . From a mechanistic viewpoint, numerous works have clearly established that the transfers of PL from VLDL to HDL occurs either as spontaneous transfers (16) or as phospholipid transfer protein-facilitated tranfers (17) (18) . On the basis of these mechanisms, it is clear that not all of the PL released from VLDL are necessarily transferred to HDL and that a part of them may be taken up by other acceptors.
Up to now, the possibility that a transfer of PL from VLDL to platelets may occur has never been considered. In the present work, we present in vitro evidences showing that this transfer may occur under physiological conditions, is facilitated by the action of LPL and is dependent upon the activation of platelets. 
MATERIALS AND METHODS

Materials
Platelet aggregation
To avoid abnormal experimental data that could result from unknown medical treatment taken by blood donors, each platelet preparation was controlled for its functional ability to aggregate before being used in our studies. Aggregations were induced by arachidonic acid and performed in a Chronolog dual-channel aggregometer (Coulter, Margency, France) according to the turbidimetric method of Born (22) . 
Transfers of labelled phospholipids from lipoprotein fractions to platelets
Determination of thromboxane B 2 production
The production of TXB 2 by platelets was determined at the beginning and at the end of incubations carried out under various conditions as described above. However, platelets were not separated from their media before the TXB 2 assay, thereby permitting the measurement of total TXB 2 .
Determination of lipoprotein lipase activity
The time-course of LPL-mediated hydrolysis of VLDL TG was monitored by measuring the release of NEFA as previously described (24) . These determinations were performed during specifically designed incubations carried out either in the presence or absence of LPL.
RESULTS
The transfers of [ 14 C]PAPC from VLDL, LDL or HDL to platelets were compared after one hour incubations at 37°C (Fig. 1A) . At identical concentrations of PL, VLDL and LDL elicited comparable transfers while HDL was a rather poor PL donor. from VLDL to platelets during incubations performed in the presence of thrombin (Fig. 4) . The results clearly exhibited a concentration-dependent stimulating effect of thrombin. We therefore compared the effects of thrombin and LPL on platelet TxB 2 production (Fig. 5) . While VLDL alone were unable to stimulate the production of TXB 2 by platelets, the latter was strongly enhanced by either LPL or thrombin. Interestingly, when the incubations were performed in the absence of VLDL, the stimulating effect of thrombin was maintained whereas that of LPL was totally inhibited, showing that the LPLdependent activation of platelets resulted from its ability to stimulate VLDL lipolysis. Since the LPLmediated hydrolysis of VLDL TG generates the release of free fatty acids, we performed incubations in the presence of FAF-albumin. Under these conditions, the stimulating effects of LPL on both the transfer of [ 14 C]PAPC to platelets (Fig. 6A ) and the production of TxB 2 by platelets (Fig. 6B) were abolished.
In vivo, the major part of PL released during VLDL lipolysis is believed to be taken up by HDL. We therefore tested the possibility that HDL could antagonize the transfer of [ 14 C]PAPC from VLDL to platelets. At a physiological concentration, HDL abolished the effect of LPL on the PL transfer to platelets (Fig. 7A) while it had no effect on the LPL-stimulated production of TXB 2 by platelets (Fig.   7B ). To mimic pathophysiological conditions of hypertriglyceridemia, we measured LPL-stimulated tranfers of [ 14 C]PAPC from elevated concentration of VLDL (1 µmol/mL of PL) to platelets in the presence of various concentrations of HDL (Fig. 8) . Although increasing concentrations of HDL were able to progressively antagonize the transfers observed, the latter remained significantly higher than those of controls even at the most elevated concentration of HDL tested. (Fig. 9) . In all cases, the stimulating effects of both LPL and thrombin had similar magnitudes.
DISCUSSION
Previous works have shown that LDL and HDL were able to transfer PL to platelets (8) (9) . Our data demonstrate that in addition VLDL-associated PL can also be transferred to platelets, and that these transfers are favored by LPL. It is important to notice that, with the exception of specifically designed experiments (see below), both the concentrations of VLDL and platelets used in the incubations were in the normal physiological range. As to LPL, the concentrations of 100 and 500 ng/mL corresponded to the basal and postheparinic plasma concentrations, respectively (25 platelets as an index of their degree of activation (1) (2) . LPL clearly stimulated the production of TxB 2 by platelets, but this was true only in the presence of VLDL, ruling out the possibility of a direct effect of LPL on platelet activation. LPL-mediated TG hydrolysis directly generates several products, including fatty acids as well as mono and diacylglycerols, that could be taken up by platelets. Since in our experiments TG were not labelled, no direct information concerning the putative silent transfers of these products can be drawn from our data. However, when the incubations were performed in the presence of FAF-albumin to adsorb the fatty acids generated during VLDL lipolysis, the production of TXB 2 was no more stimulated by LPL. Thus, albeit non excluding the possibility of transfers of other molecular species, these data suggest that the fatty acids released during LPL-mediated VLDL lipolysis might favor platelet activation, in particular through the action of arachidonic acid (28) (29) .
The stimulating effect of LPL on PL transfers was also inhibited in the presence of FAF-albumin favoring the concept that the VLDL-associated PL transfers might be stimulated by platelet activation. Interestingly, when LPL-stimulated PL transfers were antagonized by HDL, no decrease of TxB 2 production was observed, showing that the import of PL by platelets is not necessary to their short-term activation process. Moreover, thrombin stimulated both TxB 2 production and transfers of PL, confirming that platelet activation resulted in the enhancement of PL import from VLDL.
Two informations concerning the mechanism underlying the import of PL from VLDL to platelets can be drawn from the comparison of our data to those of previous reports. Firstly, Since VLDL has been shown to bind to the platelet receptor CD36 (30), one could hypothesize that PL transfer could occur during this interaction. If this was true, one would not have expected an antagonizing effect of HDL.
Indeed, the transfers of PL from VLDL to HDL occur either as spontaneous molecular transfers or as phospholipid transfer protein (PLTP)-facilitated transfers through the aqueous phase (16) (17) (18) . Thus, it appears likely that the transfers of PL from VLDL to platelets result from a similar mechanism. To further explore this point we have undertaken a specific series of experiments designed to study the regulation of these transfers. Preliminary data suggest that they can be stimulated by PLTP (unshown results). The second observation relates to the apparent non specificity of the PL species transferred from VLDL to platelets. Both LPL and thrombin stimulated the import by platelets of VLDL-derived PAPC, PAPE and DPPC with similar efficiencies. These results are in marked contrast with those of a previously published work (11) . These authors compared the transfers of various PL from LDL to platelets. The transfers of PC and sphingomyelin were unaffected by thrombin while the latter accelerated that of PE species. In addition this PE import was related to the activation of protein kinase C and to the secretion by platelets of an unknown proteinaceous factor. Thus the regulation of the PL uptake by platelets appears to dramatically depend upon the lipoprotein used as the donor. While LDL might preferentially transfer certain PL species, namely PE, by a specific mechanism, VLDL could supply all types of PL to platelets without consideration of their nature.
The pathophysiological relevance of our data deserves several considerations. Firstly, to avoid the uncontrolled actions of numerous factors on platelet activation, we carried out the platelet incubations in a serum-free medium. Thus, we cannot exclude that the effects of LPL observed in vitro might be The concentrations of thromboxane B 2 (TxB 2 ) were measured using a commercial kit as described in "Materials and Methods". The results were expressed as the amounts of TxB 2 produced by 3.10 
